Suchergebnisse - "IFN-β-1a"

PubPharm (24)

1

Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic

enthalten in: Acta neurologica Belgica | 2024

von Todorović, S. | Vojinović, S. | Savić, D. | +2

2

Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2023

von Nguyen, K. | Olcer, M. | Howlett-Prieto, Q. | +2

3

Comparative study of commercial media to improve GMP manufacturing of recombinant human interferon β-1a by CHO cells in perfusion bioreactor

enthalten in: Cytotechnology | 2022

von Sedighikamal, H. | Karimi Mostofi, R. | Sattarzadeh, A. | +2

4

Study of the effects of interferon β-1a on hospitalized patients with COVID-19 : SBMU Taskforce on the COVIFERON study

enthalten in: Journal of medical virology | 2022

von Fallahzadeh, M. | Pourhoseingholi, M. | Boroujeni, M. | +12

5

Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis : results of 52 weeks of therapy in a randomized, double-blind clinical trial

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022

von Boyko, A. | Boyko, O. | Bakhtiyarova, K. | +15

6

New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»)

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022

von Spirin, N. | Vlasov, Y. | Zakharova, M. | +11

7

The effect of IFN-β 1a on expression of MDA5 and RIG-1 in multiple sclerosis patients

enthalten in: Biotechnology and applied biochemistry | 2021

von Asadikaram, G. | Meimand, H. | Noroozi, S. | +3

8

Potential COVID-19 Therapeutic Agents and Vaccines : An Evidence-Based Review

enthalten in: Journal of clinical pharmacology | 2021

von Khani, E. | Khiali, S. | Entezari-Maleki, T.

9

Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

enthalten in: International immunopharmacology | 2021

von Baghaei, P. | Dastan, F. | Marjani, M. | +14

10

Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)

enthalten in: Frontiers in neurology | 2021

von Centonze, D. | Fantozzi, R. | Buttari, F. | +8